nct_id,study_title,registry_links,study_type,overall_status,registry_linked_pubs_cnt,abstract_linked_pubs_cnt,vaccine_trial_flag,Number_of_updates,US_site_flag,Has_Results
NCT04251871,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04251871,Interventional,Recruiting,1,0,0,1,0,0
NCT04252274,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,https://clinicaltrials.gov/ct2/show/NCT04252274,Interventional,Recruiting,1,0,0,2,0,0
NCT04252885,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,https://clinicaltrials.gov/ct2/show/NCT04252885,Interventional,Completed,1,0,0,1,0,0
NCT04257656,A Trial of Remdesivir in Adults With Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04257656,Interventional,Terminated,2,0,0,3,0,0
NCT04261517,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,https://clinicaltrials.gov/ct2/show/NCT04261517,Interventional,Completed,1,0,0,3,0,0
NCT04262921,French COVID Cohort,https://clinicaltrials.gov/ct2/show/NCT04262921,Observational,Recruiting,2,0,0,2,0,0
NCT04264533,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04264533,Interventional,Terminated,1,0,0,2,0,0
NCT04276688,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",https://clinicaltrials.gov/ct2/show/NCT04276688,Interventional,Completed,2,0,0,2,0,0
NCT04279782,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,https://clinicaltrials.gov/ct2/show/NCT04279782,Observational,Recruiting,1,0,0,1,0,0
NCT04279899,The Investigation of the Neonates With or With Risk of COVID-19,https://clinicaltrials.gov/ct2/show/NCT04279899,Observational,Recruiting,1,0,0,0,0,0
NCT04280705,Adaptive COVID-19 Treatment Trial (ACTT),https://clinicaltrials.gov/ct2/show/NCT04280705,Interventional,Completed,1,0,0,22,1,1
NCT04282135,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,https://clinicaltrials.gov/ct2/show/NCT04282135,Observational,Completed,1,0,0,1,0,0
NCT04283461,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04283461,Interventional,"Active, not recruiting",2,0,1,10,1,0
NCT04290780,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,https://clinicaltrials.gov/ct2/show/NCT04290780,Observational,Recruiting,1,0,0,5,0,0
NCT04292730,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,https://clinicaltrials.gov/ct2/show/NCT04292730,Interventional,Completed,1,0,0,18,1,0
NCT04292899,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04292899,Interventional,Completed,1,0,0,19,1,0
NCT04292964,Prognostic Factors of Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04292964,Observational,Completed,1,0,0,3,0,0
NCT04305574,Social Media Use During COVID-19,https://clinicaltrials.gov/ct2/show/NCT04305574,Observational,Completed,1,0,0,2,0,0
NCT04306393,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04306393,Interventional,Recruiting,1,0,0,7,1,0
NCT04307459,Acute Respiratory Failure and COVID-19 in Real Life,https://clinicaltrials.gov/ct2/show/NCT04307459,Observational,Recruiting,1,0,0,3,0,0
NCT04308668,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,https://clinicaltrials.gov/ct2/show/NCT04308668,Interventional,Completed,3,1,0,9,1,0
NCT04311177,Losartan for Patients With COVID-19 Not Requiring Hospitalization,https://clinicaltrials.gov/ct2/show/NCT04311177,Interventional,Recruiting,1,0,0,7,1,0
NCT04312009,Losartan for Patients With COVID-19 Requiring Hospitalization,https://clinicaltrials.gov/ct2/show/NCT04312009,Interventional,Recruiting,1,0,0,10,1,0
NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,https://clinicaltrials.gov/ct2/show/NCT04313127,Interventional,"Active, not recruiting",1,0,1,4,0,0
NCT04315948,Trial of Treatments for COVID-19 in Hospitalized Adults,https://clinicaltrials.gov/ct2/show/NCT04315948,Interventional,Recruiting,2,0,0,5,0,0
NCT04316377,Norwegian Coronavirus Disease 2019 Study,https://clinicaltrials.gov/ct2/show/NCT04316377,Interventional,"Active, not recruiting",2,0,0,3,0,0
NCT04316949,Predictors of Respiratory Failure in SARS-Cov-2 Infection,https://clinicaltrials.gov/ct2/show/NCT04316949,Observational,Recruiting,1,0,0,4,0,0
NCT04317092,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),https://clinicaltrials.gov/ct2/show/NCT04317092,Interventional,"Active, not recruiting",3,0,0,3,0,0
NCT04318366,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",https://clinicaltrials.gov/ct2/show/NCT04318366,Observational,Recruiting,7,0,0,2,0,0
NCT04318418,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",https://clinicaltrials.gov/ct2/show/NCT04318418,Observational,Completed,1,0,0,1,0,0
NCT04321278,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),https://clinicaltrials.gov/ct2/show/NCT04321278,Interventional,Completed,2,0,0,5,0,0
NCT04321369,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,https://clinicaltrials.gov/ct2/show/NCT04321369,Observational,Completed,0,1,0,1,1,0
NCT04321421,Hyperimmune Plasma for Critical Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04321421,Interventional,Completed,3,0,0,2,0,0
NCT04321928,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,https://clinicaltrials.gov/ct2/show/NCT04321928,Interventional,Recruiting,1,0,0,2,0,0
NCT04322123,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04322123,Interventional,"Active, not recruiting",1,0,0,6,0,0
NCT04322396,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04322396,Interventional,Recruiting,2,0,0,3,0,0
NCT04323527,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,https://clinicaltrials.gov/ct2/show/NCT04323527,Interventional,Completed,1,0,0,3,0,0
NCT04323592,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,https://clinicaltrials.gov/ct2/show/NCT04323592,Observational [Patient Registry],Completed,1,0,0,6,0,1
NCT04323644,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),https://clinicaltrials.gov/ct2/show/NCT04323644,Observational,Recruiting,1,0,0,1,0,0
NCT04323839,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),https://clinicaltrials.gov/ct2/show/NCT04323839,Observational [Patient Registry],Enrolling by invitation,1,0,0,4,1,0
NCT04324606,A Study of a Candidate COVID-19 Vaccine (COV001),https://clinicaltrials.gov/ct2/show/NCT04324606,Interventional,"Active, not recruiting",1,0,1,11,0,0
NCT04324736,"""COVID-19 and Diabetes Outcomes""",https://clinicaltrials.gov/ct2/show/NCT04324736,Observational,"Active, not recruiting",2,0,0,6,0,0
NCT04326790,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,https://clinicaltrials.gov/ct2/show/NCT04326790,Interventional,Recruiting,2,0,0,4,0,0
NCT04326920,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),https://clinicaltrials.gov/ct2/show/NCT04326920,Interventional,Recruiting,2,0,0,3,0,0
NCT04327206,BCG Vaccination to Protect Healthcare Workers Against COVID-19,https://clinicaltrials.gov/ct2/show/NCT04327206,Interventional,Recruiting,1,0,1,9,0,0
NCT04327401,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,https://clinicaltrials.gov/ct2/show/NCT04327401,Interventional,Terminated,1,0,0,5,0,0
NCT04327531,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",https://clinicaltrials.gov/ct2/show/NCT04327531,Observational,Completed,1,0,0,4,0,0
NCT04328441,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,https://clinicaltrials.gov/ct2/show/NCT04328441,Interventional,"Active, not recruiting",1,0,1,3,0,0
NCT04328480,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,https://clinicaltrials.gov/ct2/show/NCT04328480,Interventional,Recruiting,0,1,0,1,0,0
NCT04328493,The Vietnam Chloroquine Treatment on COVID-19,https://clinicaltrials.gov/ct2/show/NCT04328493,Interventional,Recruiting,1,0,0,3,0,0
NCT04328961,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),https://clinicaltrials.gov/ct2/show/NCT04328961,Interventional,Completed,1,0,0,5,1,0
NCT04329832,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,https://clinicaltrials.gov/ct2/show/NCT04329832,Interventional,"Active, not recruiting",2,0,0,3,1,0
NCT04329923,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),https://clinicaltrials.gov/ct2/show/NCT04329923,Interventional,Recruiting,1,0,0,3,1,0
NCT04330586,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,https://clinicaltrials.gov/ct2/show/NCT04330586,Interventional,Recruiting,1,0,0,1,0,0
NCT04330638,Treatment of COVID-19 Patients With Anti-interleukin Drugs,https://clinicaltrials.gov/ct2/show/NCT04330638,Interventional,Recruiting,1,0,0,5,0,0
NCT04331171,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,https://clinicaltrials.gov/ct2/show/NCT04331171,Observational [Patient Registry],Recruiting,1,0,0,3,0,0
NCT04331470,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,https://clinicaltrials.gov/ct2/show/NCT04331470,Interventional,Recruiting,1,0,0,2,0,0
NCT04331509,COVID-19 Symptom Tracker,https://clinicaltrials.gov/ct2/show/NCT04331509,Observational,Recruiting,1,0,0,2,1,0
NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,https://clinicaltrials.gov/ct2/show/NCT04331574,Observational [Patient Registry],Recruiting,2,0,0,0,0,0
NCT04331808,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),https://clinicaltrials.gov/ct2/show/NCT04331808,Interventional,"Active, not recruiting",1,0,0,2,0,0
NCT04332991,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,https://clinicaltrials.gov/ct2/show/NCT04332991,Interventional,Completed,2,0,0,6,1,0
NCT04333420,"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",https://clinicaltrials.gov/ct2/show/NCT04333420,Interventional,Recruiting,1,0,0,4,0,0
NCT04333589,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,https://clinicaltrials.gov/ct2/show/NCT04333589,Interventional,Recruiting,1,0,0,2,0,0
NCT04333849,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,https://clinicaltrials.gov/ct2/show/NCT04333849,Observational,Completed,1,0,0,2,0,0
NCT04333875,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,https://clinicaltrials.gov/ct2/show/NCT04333875,Observational [Patient Registry],"Active, not recruiting",0,2,0,2,0,0
NCT04334265,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,https://clinicaltrials.gov/ct2/show/NCT04334265,Interventional,Recruiting,1,0,0,1,0,0
NCT04334291,"International COVID19 Clinical Evaluation Registry,",https://clinicaltrials.gov/ct2/show/NCT04334291,Observational [Patient Registry],Recruiting,3,0,0,1,0,0
NCT04335123,Study of Open Label Losartan in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04335123,Interventional,Completed,1,0,0,3,1,0
NCT04335162,Cardiovascular Complications and COVID-19 (CovCardioVasc),https://clinicaltrials.gov/ct2/show/NCT04335162,Observational,Recruiting,1,0,0,2,0,0
NCT04335786,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,https://clinicaltrials.gov/ct2/show/NCT04335786,Interventional,Recruiting,1,0,0,6,0,0
NCT04336254,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04336254,Interventional,Recruiting,1,0,0,0,0,0
NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,https://clinicaltrials.gov/ct2/show/NCT04336345,Observational [Patient Registry],Completed,1,0,0,6,0,0
NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,https://clinicaltrials.gov/ct2/show/NCT04337541,Interventional,Completed,1,0,0,1,0,0
NCT04338568,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,https://clinicaltrials.gov/ct2/show/NCT04338568,Interventional,Recruiting,0,1,0,3,0,0
NCT04338672,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,https://clinicaltrials.gov/ct2/show/NCT04338672,Observational,Recruiting,1,0,0,1,0,0
NCT04338698,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",https://clinicaltrials.gov/ct2/show/NCT04338698,Interventional,Recruiting,1,0,0,2,0,0
NCT04338841,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,https://clinicaltrials.gov/ct2/show/NCT04338841,Interventional,Completed,1,0,0,2,0,0
NCT04338958,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,https://clinicaltrials.gov/ct2/show/NCT04338958,Interventional,Recruiting,1,0,0,3,0,0
NCT04339608,Max COVID19- Study,https://clinicaltrials.gov/ct2/show/NCT04339608,Observational,Recruiting,1,0,0,0,0,0
NCT04339816,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,https://clinicaltrials.gov/ct2/show/NCT04339816,Interventional,Terminated,1,0,0,3,0,0
NCT04340050,COVID-19 Convalescent Plasma,https://clinicaltrials.gov/ct2/show/NCT04340050,Interventional,"Active, not recruiting",1,0,0,3,1,0
NCT04340349,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,https://clinicaltrials.gov/ct2/show/NCT04340349,Interventional,Enrolling by invitation,0,2,0,1,0,0
NCT04340921,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,https://clinicaltrials.gov/ct2/show/NCT04340921,Observational,Recruiting,0,6,0,1,0,0
NCT04341389,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),https://clinicaltrials.gov/ct2/show/NCT04341389,Interventional,"Active, not recruiting",1,0,1,3,0,0
NCT04341493,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04341493,Interventional,Recruiting,1,0,0,2,0,0
NCT04342182,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),https://clinicaltrials.gov/ct2/show/NCT04342182,Interventional,Recruiting,1,0,0,10,0,0
NCT04342637,COVID-19 Endoscopy Survey,https://clinicaltrials.gov/ct2/show/NCT04342637,Observational,Completed,0,5,0,3,1,0
NCT04342663,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",https://clinicaltrials.gov/ct2/show/NCT04342663,Interventional,"Active, not recruiting",1,0,0,4,1,0
NCT04343261,Convalescent Plasma in the Treatment of COVID 19,https://clinicaltrials.gov/ct2/show/NCT04343261,Interventional,Completed,3,2,0,9,1,1
NCT04343729,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,https://clinicaltrials.gov/ct2/show/NCT04343729,Interventional,"Active, not recruiting",1,0,0,6,0,0
NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",https://clinicaltrials.gov/ct2/show/NCT04343768,Interventional,Completed,1,0,0,3,0,0
NCT04343898,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04343898,Observational,"Active, not recruiting",0,8,0,8,1,0
NCT04343963,Pyridostigmine in Severe SARS-CoV-2 Infection,https://clinicaltrials.gov/ct2/show/NCT04343963,Interventional,Recruiting,1,0,0,2,0,0
NCT04343976,Pegylated Interferon Lambda Treatment for COVID-19,https://clinicaltrials.gov/ct2/show/NCT04343976,Interventional,Enrolling by invitation,1,0,0,2,1,0
NCT04344145,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,https://clinicaltrials.gov/ct2/show/NCT04344145,Observational,Completed,0,4,0,4,0,0
NCT04344197,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",https://clinicaltrials.gov/ct2/show/NCT04344197,Observational,Enrolling by invitation,1,0,0,0,0,0
NCT04344600,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,https://clinicaltrials.gov/ct2/show/NCT04344600,Interventional,Recruiting,1,0,0,3,1,0
NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",https://clinicaltrials.gov/ct2/show/NCT04344951,Interventional,Recruiting,0,3,0,1,0,0
NCT04345614,A Study of Auxora in Patients With Severe COVID-19 Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04345614,Interventional,Recruiting,1,0,0,12,1,0
NCT04345848,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,https://clinicaltrials.gov/ct2/show/NCT04345848,Interventional,Recruiting,1,0,0,2,0,0
NCT04346264,CoVid-19 - Infection and Antibody Formation in the Viennese Population,https://clinicaltrials.gov/ct2/show/NCT04346264,Observational,Enrolling by invitation,0,1,0,1,0,0
NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),https://clinicaltrials.gov/ct2/show/NCT04346342,Observational,Completed,2,0,0,3,0,0
NCT04346355,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04346355,Interventional,Terminated,1,0,0,2,0,0
NCT04347681,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04347681,Interventional,Recruiting,1,0,0,3,0,0
NCT04347941,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,https://clinicaltrials.gov/ct2/show/NCT04347941,Interventional,Recruiting,1,0,0,1,0,0
NCT04347993,"A Prospective ""Universal"" Observational Database for COVID-19",https://clinicaltrials.gov/ct2/show/NCT04347993,Observational [Patient Registry],Recruiting,2,0,0,1,1,0
NCT04348513,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04348513,Interventional,Recruiting,1,0,0,1,0,0
NCT04349202,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,https://clinicaltrials.gov/ct2/show/NCT04349202,Observational,Recruiting,1,0,0,2,1,0
NCT04351152,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04351152,Interventional,Recruiting,1,0,0,9,1,0
NCT04351516,Test and Treat COVID 65plus+,https://clinicaltrials.gov/ct2/show/NCT04351516,Interventional,"Active, not recruiting",1,0,0,5,0,0
NCT04352517,Influence Physical Activity Psychological Responses COVID-19 Pandemic,https://clinicaltrials.gov/ct2/show/NCT04352517,Observational,Recruiting,1,0,0,1,0,0
NCT04352556,COVID19-hematological Malignancies: the Italian Hematology Alliance,https://clinicaltrials.gov/ct2/show/NCT04352556,Observational,Recruiting,1,0,0,1,0,0
NCT04352764,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,https://clinicaltrials.gov/ct2/show/NCT04352764,Observational [Patient Registry],Recruiting,1,0,0,2,1,0
NCT04352959,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,https://clinicaltrials.gov/ct2/show/NCT04352959,Interventional,Recruiting,2,0,0,2,0,0
NCT04353583,Renal Outcome in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04353583,Observational [Patient Registry],Recruiting,0,1,0,5,0,0
NCT04353674,Modulation of Hyperinflammation in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04353674,Interventional,Recruiting,0,7,0,5,0,0
NCT04354259,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04354259,Interventional,Recruiting,2,0,0,1,0,0
NCT04354584,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04354584,Observational,Recruiting,1,0,0,0,0,0
NCT04354701,COVID-19 and Cancer Consortium Registry,https://clinicaltrials.gov/ct2/show/NCT04354701,Observational [Patient Registry],Recruiting,1,0,0,3,1,0
NCT04355364,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE),https://clinicaltrials.gov/ct2/show/NCT04355364,Interventional,Recruiting,1,0,0,5,0,0
NCT04355637,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04355637,Interventional,Recruiting,1,0,0,3,0,0
NCT04355936,Telmisartan for Treatment of COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04355936,Interventional,Recruiting,1,0,0,7,0,0
NCT04356482,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,https://clinicaltrials.gov/ct2/show/NCT04356482,Interventional,Recruiting,0,2,0,3,0,0
NCT04356495,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04356495,Interventional,Recruiting,1,0,0,4,0,0
NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,https://clinicaltrials.gov/ct2/show/NCT04356560,Observational,Enrolling by invitation,1,0,0,1,0,0
NCT04356937,Efficacy of Tocilizumab on Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04356937,Interventional,"Active, not recruiting",1,0,0,3,1,0
NCT04357106,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,https://clinicaltrials.gov/ct2/show/NCT04357106,Interventional,Recruiting,1,0,0,0,0,0
NCT04357730,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04357730,Interventional,Recruiting,1,0,0,7,1,0
NCT04357808,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),https://clinicaltrials.gov/ct2/show/NCT04357808,Interventional,"Active, not recruiting",1,0,0,2,0,0
NCT04358939,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),https://clinicaltrials.gov/ct2/show/NCT04358939,Interventional,Recruiting,1,0,0,6,0,0
NCT04359095,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,https://clinicaltrials.gov/ct2/show/NCT04359095,Interventional,Recruiting,0,9,0,1,0,0
NCT04359810,Plasma Therapy of COVID-19 in Severely Ill Patients,https://clinicaltrials.gov/ct2/show/NCT04359810,Interventional,Recruiting,1,0,0,3,1,0
NCT04360837,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,https://clinicaltrials.gov/ct2/show/NCT04360837,Interventional,Recruiting,0,1,0,2,0,0
NCT04360980,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04360980,Interventional,Recruiting,1,0,0,2,0,0
NCT04361474,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,https://clinicaltrials.gov/ct2/show/NCT04361474,Interventional,Recruiting,1,0,0,3,0,0
NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),https://clinicaltrials.gov/ct2/show/NCT04361942,Interventional,Recruiting,0,1,0,2,0,0
NCT04362059,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04362059,Interventional,Recruiting,0,3,0,3,0,0
NCT04363827,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04363827,Interventional,Recruiting,1,0,0,2,0,0
NCT04364802,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,https://clinicaltrials.gov/ct2/show/NCT04364802,Interventional,Recruiting,1,0,0,1,1,0
NCT04365959,The Prone Position in Covid-19 Affected Patients,https://clinicaltrials.gov/ct2/show/NCT04365959,Observational,"Active, not recruiting",1,0,0,1,0,0
NCT04366089,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,https://clinicaltrials.gov/ct2/show/NCT04366089,Interventional,Recruiting,0,4,0,0,0,0
NCT04366232,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),https://clinicaltrials.gov/ct2/show/NCT04366232,Interventional,Terminated,0,2,0,4,0,0
NCT04366882,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04366882,Interventional,Recruiting,1,0,0,0,0,0
NCT04366960,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04366960,Interventional,Recruiting,1,0,0,2,0,0
NCT04367129,Electrocardiogram Analysis in COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04367129,Observational,Recruiting,1,1,0,0,0,0
NCT04367831,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04367831,Interventional,Recruiting,1,0,0,2,1,0
NCT04367883,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",https://clinicaltrials.gov/ct2/show/NCT04367883,Observational,Recruiting,0,1,0,2,0,0
NCT04367896,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,https://clinicaltrials.gov/ct2/show/NCT04367896,Observational,Completed,0,4,0,0,0,0
NCT04368065,COVID Active Research Experience (CARE),https://clinicaltrials.gov/ct2/show/NCT04368065,Observational [Patient Registry],Recruiting,1,0,0,1,1,0
NCT04368156,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,https://clinicaltrials.gov/ct2/show/NCT04368156,Interventional,Recruiting,1,0,0,0,0,0
NCT04368351,Bacteriotherapy in the Treatment of COVID-19,https://clinicaltrials.gov/ct2/show/NCT04368351,Observational,"Active, not recruiting",0,2,0,1,0,0
NCT04368390,Neuroradiolological Analysis of COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04368390,Observational,Recruiting,1,0,0,0,0,0
NCT04368676,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,https://clinicaltrials.gov/ct2/show/NCT04368676,Interventional,Recruiting,2,0,0,1,0,0
NCT04368728,"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",https://clinicaltrials.gov/ct2/show/NCT04368728,Interventional,Recruiting,2,0,1,18,1,0
NCT04368897,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,https://clinicaltrials.gov/ct2/show/NCT04368897,Observational,Recruiting,0,4,0,2,0,0
NCT04368975,ARDS Caused by COVID-19,https://clinicaltrials.gov/ct2/show/NCT04368975,Observational [Patient Registry],Recruiting,1,0,0,0,0,0
NCT04368988,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,https://clinicaltrials.gov/ct2/show/NCT04368988,Interventional,"Active, not recruiting",2,0,1,5,1,0
NCT04369469,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04369469,Interventional,Recruiting,2,0,0,4,1,0
NCT04369807,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,https://clinicaltrials.gov/ct2/show/NCT04369807,Observational,Recruiting,0,12,0,0,0,0
NCT04370067,HUNgarian COronaVirus Disease-19 Epidemiological Research,https://clinicaltrials.gov/ct2/show/NCT04370067,Observational [Patient Registry],Recruiting,1,0,0,2,0,0
NCT04370288,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04370288,Interventional,Recruiting,1,0,0,1,0,0
NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),https://clinicaltrials.gov/ct2/show/NCT04372589,Interventional,Recruiting,2,0,0,2,1,0
NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,https://clinicaltrials.gov/ct2/show/NCT04373291,Interventional,Recruiting,1,0,1,2,0,0
NCT04374123,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,https://clinicaltrials.gov/ct2/show/NCT04374123,Observational,Completed,0,3,0,1,0,0
NCT04374422,COVID-19 Pandemic and Female Sexual Behavior,https://clinicaltrials.gov/ct2/show/NCT04374422,Observational,Completed,0,1,0,0,0,0
NCT04374526,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,https://clinicaltrials.gov/ct2/show/NCT04374526,Interventional,Recruiting,1,0,0,2,0,0
NCT04374786,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,https://clinicaltrials.gov/ct2/show/NCT04374786,Interventional,Enrolling by invitation,0,1,0,2,1,0
NCT04375410,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,https://clinicaltrials.gov/ct2/show/NCT04375410,Observational,Enrolling by invitation,1,0,0,0,0,0
NCT04377711,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04377711,Interventional,Recruiting,1,0,0,2,1,0
NCT04377815,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,https://clinicaltrials.gov/ct2/show/NCT04377815,Observational,Recruiting,1,0,0,0,0,0
NCT04378582,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,https://clinicaltrials.gov/ct2/show/NCT04378582,Observational,Completed,1,0,0,3,0,0
NCT04378595,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,https://clinicaltrials.gov/ct2/show/NCT04378595,Observational,Recruiting,1,0,0,1,1,0
NCT04378738,Social Media and Covid19 Pandemic,https://clinicaltrials.gov/ct2/show/NCT04378738,Interventional,Enrolling by invitation,0,1,0,0,0,0
NCT04380818,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,https://clinicaltrials.gov/ct2/show/NCT04380818,Interventional,Recruiting,1,0,0,2,0,0
NCT04381936,Randomised Evaluation of COVID-19 Therapy,https://clinicaltrials.gov/ct2/show/NCT04381936,Interventional,Recruiting,3,3,0,5,0,0
NCT04381962,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),https://clinicaltrials.gov/ct2/show/NCT04381962,Interventional,Recruiting,1,0,0,1,0,0
NCT04382768,Inhaled Ibuprofen to Treat COVID-19,https://clinicaltrials.gov/ct2/show/NCT04382768,Interventional,Recruiting,0,1,0,3,0,0
NCT04384380,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04384380,Interventional,Completed,0,5,0,1,0,0
NCT04385043,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,https://clinicaltrials.gov/ct2/show/NCT04385043,Interventional,Recruiting,0,1,0,0,0,0
NCT04385095,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,https://clinicaltrials.gov/ct2/show/NCT04385095,Interventional,Recruiting,1,0,0,1,0,0
NCT04385901,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,https://clinicaltrials.gov/ct2/show/NCT04385901,Interventional,Recruiting,0,1,0,2,1,0
NCT04386395,Immune Changes in Severe COVID-19 Pulmonary Infections,https://clinicaltrials.gov/ct2/show/NCT04386395,Observational,"Active, not recruiting",1,0,0,0,0,0
NCT04389840,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,https://clinicaltrials.gov/ct2/show/NCT04389840,Interventional,Recruiting,1,0,0,10,1,0
NCT04390464,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),https://clinicaltrials.gov/ct2/show/NCT04390464,Interventional,Recruiting,1,0,0,1,0,0
NCT04391140,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,https://clinicaltrials.gov/ct2/show/NCT04391140,Interventional,Recruiting,1,0,0,2,0,0
NCT04391829,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,https://clinicaltrials.gov/ct2/show/NCT04391829,Interventional,Recruiting,0,1,0,1,0,0
NCT04392245,Proctologic Practice and Covid-19,https://clinicaltrials.gov/ct2/show/NCT04392245,Observational,Completed,1,0,0,0,0,0
NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,https://clinicaltrials.gov/ct2/show/NCT04392323,Interventional,Recruiting,0,12,0,0,1,0
NCT04392713,Efficacy of Ivermectin in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04392713,Interventional,Recruiting,0,1,0,0,0,0
NCT04392973,FAvipiravir and HydroxyChloroquine Combination Therapy,https://clinicaltrials.gov/ct2/show/NCT04392973,Interventional,Recruiting,1,0,0,2,0,0
NCT04393246,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,https://clinicaltrials.gov/ct2/show/NCT04393246,Interventional,Recruiting,1,0,0,2,0,0
NCT04393636,Digital Cardiac Counseling Trial: DCC Trial,https://clinicaltrials.gov/ct2/show/NCT04393636,Interventional,Recruiting,0,1,0,1,0,0
NCT04393727,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04393727,Interventional,Terminated,0,1,0,2,0,0
NCT04394000,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04394000,Observational [Patient Registry],Completed,1,0,0,0,0,0
NCT04394182,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,https://clinicaltrials.gov/ct2/show/NCT04394182,Interventional,Recruiting,0,4,0,0,0,0
NCT04394416,Trial of Imatinib for Hospitalized Adults With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04394416,Interventional,Recruiting,2,0,0,1,1,0
NCT04395105,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",https://clinicaltrials.gov/ct2/show/NCT04395105,Interventional,Recruiting,1,0,0,3,0,0
NCT04395144,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,https://clinicaltrials.gov/ct2/show/NCT04395144,Interventional,Recruiting,1,0,0,1,0,0
NCT04396197,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,https://clinicaltrials.gov/ct2/show/NCT04396197,Observational,Completed,1,0,0,0,0,0
NCT04399317,Flow Controlled Ventilation in ARDS Associated With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04399317,Interventional,Recruiting,1,0,0,1,0,0
NCT04400799,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04400799,Interventional,Recruiting,1,0,0,1,0,0
NCT04401202,Nigella Sativa in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04401202,Interventional,Recruiting,1,0,0,0,0,0
NCT04401540,Characteristics of Neonatal Covid-19 in Turkey,https://clinicaltrials.gov/ct2/show/NCT04401540,Observational [Patient Registry],Recruiting,1,3,0,2,0,0
NCT04402853,SARS Cov-2 in Conjunctival Secretion,https://clinicaltrials.gov/ct2/show/NCT04402853,Observational,Completed,0,1,0,0,0,0
NCT04403477,Convalescent Plasma Therapy in Severe COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04403477,Interventional,Recruiting,1,0,0,0,0,0
NCT04407156,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,https://clinicaltrials.gov/ct2/show/NCT04407156,Observational,Completed,1,0,0,2,0,0
NCT04407468,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04407468,Observational,Completed,0,7,0,1,0,0
NCT04407689,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,https://clinicaltrials.gov/ct2/show/NCT04407689,Interventional,Recruiting,0,2,0,1,0,0
NCT04410328,Aggrenox To Treat Acute Covid-19,https://clinicaltrials.gov/ct2/show/NCT04410328,Interventional,Recruiting,0,2,0,4,1,0
NCT04410562,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy,https://clinicaltrials.gov/ct2/show/NCT04410562,Interventional,Recruiting,1,0,0,0,0,0
NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04411446,Interventional,Recruiting,0,1,0,3,0,0
NCT04411459,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,https://clinicaltrials.gov/ct2/show/NCT04411459,Observational,Completed,1,3,0,2,0,0
NCT04412057,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,https://clinicaltrials.gov/ct2/show/NCT04412057,Interventional,Recruiting,1,0,0,5,1,0
NCT04412538,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,https://clinicaltrials.gov/ct2/show/NCT04412538,Interventional,Recruiting,1,0,1,1,0,0
NCT04416100,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04416100,Observational,Recruiting,1,0,0,0,0,0
NCT04416399,STerOids in COVID-19 Study,https://clinicaltrials.gov/ct2/show/NCT04416399,Interventional,Recruiting,1,0,0,3,0,0
NCT04416919,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,https://clinicaltrials.gov/ct2/show/NCT04416919,Interventional,Recruiting,0,1,0,1,1,0
NCT04418518,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,https://clinicaltrials.gov/ct2/show/NCT04418518,Interventional,Recruiting,0,1,0,1,1,0
NCT04418557,COVID-19 and Obstetric Transmission,https://clinicaltrials.gov/ct2/show/NCT04418557,Observational [Patient Registry],Recruiting,0,2,0,1,1,0
NCT04420741,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,https://clinicaltrials.gov/ct2/show/NCT04420741,Interventional,Recruiting,1,0,0,5,0,0
NCT04422535,Effects on the Qt Interval of COVID-19 Coronavirus Infection,https://clinicaltrials.gov/ct2/show/NCT04422535,Observational,Recruiting,0,2,0,0,0,0
NCT04423770,COVID-19 Related Health and Infection Control Practices Among Dentists,https://clinicaltrials.gov/ct2/show/NCT04423770,Observational,"Active, not recruiting",1,0,0,3,1,0
NCT04424836,HFNC Treatment in COVID-19 Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04424836,Observational,Completed,0,1,0,2,0,0
NCT04424953,To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn,https://clinicaltrials.gov/ct2/show/NCT04424953,Interventional,"Active, not recruiting",0,6,0,1,0,0
NCT04427501,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,https://clinicaltrials.gov/ct2/show/NCT04427501,Interventional,Recruiting,1,0,0,20,1,0
NCT04427969,Early Prone Position on Coronavirus Disease 2019 Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04427969,Observational,Completed,0,1,0,2,0,0
NCT04428099,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,https://clinicaltrials.gov/ct2/show/NCT04428099,Interventional,Recruiting,1,0,0,0,0,0
NCT04430023,Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia,https://clinicaltrials.gov/ct2/show/NCT04430023,Observational,Completed,0,2,0,1,0,0
NCT04433910,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04433910,Interventional,Recruiting,1,0,0,1,0,0
NCT04434131,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04434131,Interventional,Recruiting,2,0,0,0,1,0
NCT04436276,A Study of Ad26.COV2.S in Adults (COVID-19),https://clinicaltrials.gov/ct2/show/NCT04436276,Interventional,Recruiting,1,0,0,5,1,0
NCT04436471,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",https://clinicaltrials.gov/ct2/show/NCT04436471,Interventional,Completed,1,0,1,3,0,0
NCT04437719,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",https://clinicaltrials.gov/ct2/show/NCT04437719,Interventional,Recruiting,0,1,0,2,0,0
NCT04437875,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",https://clinicaltrials.gov/ct2/show/NCT04437875,Interventional,Completed,1,0,1,3,0,0
NCT04437940,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,https://clinicaltrials.gov/ct2/show/NCT04437940,Observational,Recruiting,0,1,0,0,0,0
NCT04438629,Evaluation of Immune Response in COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04438629,Observational,Recruiting,1,0,0,1,0,0
NCT04441424,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,https://clinicaltrials.gov/ct2/show/NCT04441424,Interventional,Completed,1,0,0,1,0,0
NCT04441489,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04441489,Observational,Completed,1,0,0,0,0,0
NCT04441814,FOUND - Ancillary Study to Smile Protocol NCT03654105,https://clinicaltrials.gov/ct2/show/NCT04441814,Observational,Enrolling by invitation,0,4,0,1,0,0
NCT04442178,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),https://clinicaltrials.gov/ct2/show/NCT04442178,Interventional,Recruiting,0,2,0,1,1,0
NCT04443140,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,https://clinicaltrials.gov/ct2/show/NCT04443140,Observational [Patient Registry],Completed,0,1,0,2,0,0
NCT04445467,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04445467,Interventional,Recruiting,1,0,0,1,0,0
NCT04445935,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,https://clinicaltrials.gov/ct2/show/NCT04445935,Interventional,Recruiting,1,0,0,0,0,0
NCT04445961,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,https://clinicaltrials.gov/ct2/show/NCT04445961,Observational,Completed,0,2,0,1,0,0
NCT04448717,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,https://clinicaltrials.gov/ct2/show/NCT04448717,Observational,Recruiting,1,0,0,1,0,0
NCT04449731,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),https://clinicaltrials.gov/ct2/show/NCT04449731,Observational,Recruiting,0,2,0,3,0,0
NCT04453579,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",https://clinicaltrials.gov/ct2/show/NCT04453579,Observational [Patient Registry],Completed,0,2,0,0,0,0
NCT04454606,The New Silicone N99 Half-Piece Respirator,https://clinicaltrials.gov/ct2/show/NCT04454606,Interventional,Completed,0,1,0,0,0,0
NCT04459819,Respiratory Physiotherapy in Severe COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04459819,Observational,Recruiting,0,2,0,1,0,0
NCT04466670,Hemostasis in COVID-19: an Adaptive Clinical Trial,https://clinicaltrials.gov/ct2/show/NCT04466670,Interventional,Recruiting,0,29,0,0,0,0
NCT04468035,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,https://clinicaltrials.gov/ct2/show/NCT04468035,Observational,Recruiting,0,2,0,2,0,0
NCT04471701,Italian Web-based Cross-sectional Survey on COVID-19,https://clinicaltrials.gov/ct2/show/NCT04471701,Observational,Recruiting,1,0,0,1,0,0
NCT04475471,WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,https://clinicaltrials.gov/ct2/show/NCT04475471,Observational,Recruiting,0,5,0,1,0,0
NCT04476589,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,https://clinicaltrials.gov/ct2/show/NCT04476589,Observational,Recruiting,0,1,0,1,1,0
NCT04479202,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,https://clinicaltrials.gov/ct2/show/NCT04479202,Interventional,Completed,0,3,0,0,0,0
NCT04480034,Obesity Surgery During 2020 Italian Pandemic,https://clinicaltrials.gov/ct2/show/NCT04480034,Observational,Recruiting,0,9,0,1,0,0
NCT04480593,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,https://clinicaltrials.gov/ct2/show/NCT04480593,Interventional,Completed,0,4,0,1,0,0
NCT04486404,"Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",https://clinicaltrials.gov/ct2/show/NCT04486404,Observational,Enrolling by invitation,1,0,0,3,0,0
NCT04486508,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04486508,Interventional,Recruiting,0,1,0,4,0,0
NCT04487990,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04487990,Interventional,Recruiting,1,0,0,0,0,0
NCT04488484,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,https://clinicaltrials.gov/ct2/show/NCT04488484,Interventional,"Active, not recruiting",0,4,0,1,0,0
NCT04494724,Clazakizumab vs. Placebo - COVID-19 Infection,https://clinicaltrials.gov/ct2/show/NCT04494724,Interventional,Recruiting,0,5,0,0,1,0
NCT04497311,Tomographic Findings in COVID-19 and Influenza,https://clinicaltrials.gov/ct2/show/NCT04497311,Observational,Recruiting,0,5,0,1,0,0
NCT04501965,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04501965,Interventional,Enrolling by invitation,0,10,0,1,0,0
NCT04503434,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,https://clinicaltrials.gov/ct2/show/NCT04503434,Observational [Patient Registry],Completed,0,1,0,0,0,0
NCT04507282,Eosinophil and Anticoagulation in COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04507282,Observational,Completed,1,0,0,1,0,0
NCT04511429,COVID-19 in Immunosuppressed Children,https://clinicaltrials.gov/ct2/show/NCT04511429,Observational [Patient Registry],Recruiting,0,4,0,0,0,0
NCT04514705,Characteristics in Post Covid-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04514705,Interventional,Recruiting,0,6,0,0,0,0
NCT04515108,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,https://clinicaltrials.gov/ct2/show/NCT04515108,Observational,Completed,0,4,0,0,0,0
NCT04516811,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,https://clinicaltrials.gov/ct2/show/NCT04516811,Interventional,Recruiting,0,1,0,2,0,0
NCT04517162,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04517162,Interventional,Recruiting,0,14,0,2,0,0
NCT04517422,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,https://clinicaltrials.gov/ct2/show/NCT04517422,Interventional,Recruiting,0,7,0,3,0,0
NCT04521309,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04521309,Interventional,Recruiting,1,0,0,1,0,0
NCT04522492,Impact of COVID-19 on Mental Health of Patients With Skin Picking,https://clinicaltrials.gov/ct2/show/NCT04522492,Interventional,Enrolling by invitation,0,1,0,0,0,0
NCT04526405,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,https://clinicaltrials.gov/ct2/show/NCT04526405,Observational,Completed,0,4,0,1,0,0
NCT04529525,Ivermectin to Prevent Hospitalizations in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04529525,Interventional,Recruiting,0,2,0,3,0,0
NCT04530617,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,https://clinicaltrials.gov/ct2/show/NCT04530617,Interventional,Recruiting,0,12,0,3,0,0
NCT04555096,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,https://clinicaltrials.gov/ct2/show/NCT04555096,Interventional,Recruiting,1,0,0,2,1,0
NCT04557605,Effects of a Face Mask on Oxygenation During Exercise,https://clinicaltrials.gov/ct2/show/NCT04557605,Interventional,Completed,1,0,0,1,0,0
NCT04558996,Spanish Registry of Pregnant Women With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04558996,Observational [Patient Registry],Recruiting,0,1,0,0,0,0
NCT04567927,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04567927,Observational,Completed,0,6,0,0,0,0
NCT04567979,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,https://clinicaltrials.gov/ct2/show/NCT04567979,Observational,"Active, not recruiting",0,12,0,0,0,0
NCT04568356,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,https://clinicaltrials.gov/ct2/show/NCT04568356,Interventional,Completed,0,16,0,1,1,0
NCT04577105,Risk Factors and Computed Tomography Findings in COVID-19.,https://clinicaltrials.gov/ct2/show/NCT04577105,Observational,Completed,0,6,0,1,0,0
NCT04597034,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04597034,Interventional,Recruiting,0,2,0,0,0,0
NCT04604249,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,https://clinicaltrials.gov/ct2/show/NCT04604249,Observational,Recruiting,0,6,0,0,0,0
NCT04610541,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,https://clinicaltrials.gov/ct2/show/NCT04610541,Interventional,Recruiting,0,5,0,0,0,0
NCT04610567,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),https://clinicaltrials.gov/ct2/show/NCT04610567,Interventional,Recruiting,0,4,0,1,0,0
NCT04611269,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,https://clinicaltrials.gov/ct2/show/NCT04611269,Observational [Patient Registry],Completed,0,7,0,3,0,0
NCT04623697,Covid-19 Infection and New Onset Type 1 Diabetes,https://clinicaltrials.gov/ct2/show/NCT04623697,Observational [Patient Registry],Recruiting,0,1,0,0,0,0
NCT04624503,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,https://clinicaltrials.gov/ct2/show/NCT04624503,Observational,Recruiting,0,1,0,0,0,0
NCT04627467,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),https://clinicaltrials.gov/ct2/show/NCT04627467,Interventional,"Active, not recruiting",0,13,0,0,0,0
